https://nl.marketscreener.com/koers/aandeel/FRACTYL-HEALTH-INC-165185650/nieuws/Fractyl-Health-Inc-Ontvangt-FDA-IDE-goedkeuring-voor-de-Revita-Remain-1-Pivotal-Studie-naar-Gew-46339969/?utm_source=telegram&utm_medium=social&utm_campaign=share